1/Opioid crisis roars back in Alabama as overdoses rise during pandemic - 32% rise in Jefferson County (where Birmingham sits). Loss of human contact is part of the story told by Cassidy Cooper and me. al.com/news/2020/09/o…
2/Cassidy has lost 6 friends in the Huntsville area. He finished a rehab program in March:"Restrictions enacted to prevent the spread of coronavirus quickly dismantled the scaffold he built around his recovery. The gym he visited daily closed and support groups moved online."
3/ I say:
"There are people where holding their lives together and getting help really depends on going up to trusted friends and seeing them face to face, and the pandemic really takes that away,”
4/Pandemic conditions also affect naloxone distribution and drug distribution networks. The question is what can we do? The aggressive use of masks should allow us to ramp up naloxone distribution & tele-treatment. But social networks are not just made of state & county programs.
5/To the extent that we all do our utmost to prevent further viral spread, we actually can help to bring about conditions where reduced community spread allows social groups to reconnect. In the meantime I keep wondering about free phones, "call a friend", and drug testing.
1/A petition has been filed with the FDA, asking it to assess whether the "Narxcare" algorithm, which is part of prescription drug monitoring programs, should be regulated as a medical device.
FDA has rules, ones that suggest the petitioners are correct, and I signed this one
2/The Narxcare algorithm is a proprietary calculation that purports to capture overdose risk.
When docs check prescription drug monitoring programs, the score appears prominently at the top of the report, as if it should influence the prescribing decision.
3/Next Tuesday, our "On Becoming a Healer" podcast will be all about the study of how prescription drug monitoring programs influence health professionals. Special guest: @Liz_Chiarello She wrote a whole book on it!
🧵1/Our @uabmedicine Grand Rounds will feature a diagnostic showdown between Dr Martin Rodriguez and ChatGPT4
I am scared here because I don’t want AI to win
2/the case features behavioral changes, swearing, cognitive decline, cough, progressive weakness over 3 years.
I wonder about infectious and rheumatic disorders. Maybe primary neurological
Aspirations after a cognitive change is possible
Dr Rodriguez opens. Not much to go on.
3/ChatGPT generated a lot of text read by Dr Kraemer but it is pretty good, with emphasis on neurological disorders followed by a disclaimer “please note that this does not substitute for professional medical advice”. Both want more information
Truth💣 1/ The “NARXCare” opioid Rx risk algorithm is in all Prescription Monitoring Databases,ie ~1 bn Rx’s/year
NOW in @JournalGIM
✅evidence does not yet exist to support it as safe or protective
✅It has flourished due to lack of federal oversight link.springer.com/article/10.100…
2/The authors, led by Dr Michele Buonara, review the core argument as one in which this algorithm with low evidence to its favor
and high risk of harm
has gone unregulated
despite apparently fulfilling @US_FDA criteria that mandate it be regulated
3/Nearly all prescribers and national pharmacies now see the Bamboo Health, Inc proprietary “NARXcare” algorithm in a more prominent position *than the prescription history itself” when they view a prescription history.
1/Arguing for methadone deregulation, Dr. Ruth Potee notes that in an auditorium of 400 addiction specialists, almost NONE prescribe methadone (because they can't)
"Methadone is a miracle drug that no one has access to"
There are more people who offer Botox than offer methadone
Patient: “I can still do my activities”.
Doc: "No way, not really. I read the SPACE trial, and there is NO benefit (that would outweigh the opioids’ risk)”
"Shared decision-making" seems *doomed* here